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Norovirus outbreak is a major public health burden across the world. In 
immunocompromised hosts, norovirus can establish chronic infection. 
Chronically infected hosts have potential to act as a reservoir of emergent 
norovirus strain. The safe and affordable therapeutic agents to control 
chronic norovirus infection are required. Phytonutrients have been used 
as supplements in traditional medicine to enhance immune responses or 
resistance to infectious diseases. In this study, the effect of curcumin on 
chronic norovirus infection was evaluated using mouse model. C57BL/6 
mice were orally inoculated with curcumin daily for 34 days and infected 
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with murine norovirus (MNoV) CR6 strain. Viral loads were quantified 
in stool and tissue samples by realtime PCR. Curcumin reduced MNoV 
in colon and mesenteric lymph nodes (MLN). Type I interferons (IFNs) 
were also enhanced in those tissues. Inhibition was not observed in ileum 
and peyer’s patch (PP). Microbial community was assessed using 16S 
rRNA sequencing to understand tissue-specific MNoV inhibition. 
Family Mogibacteriaceae was changed significantly only in colon. 
Family Mogibacteriaceae abundance and virus quantity showed a weak 
negative correlation using correlation analysis. These results suggest that 
curcumin enhanced type I interferons in large intestines resulting in 
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Norovirus outbreak is a major public health problem across the world (1). 
This highly infectious agent spreads person to person via a fecal-oral 
route (2). Though it causes acute gastroenteritis lasting 2 or 3 days and 
self-limited symptom (3), norovirus can establish chronic infection in 
immunocompromised hosts such as the elderly, malnourished 
individuals (4, 5). Chronically infected hosts have potential to act as a 
reservoir of emergent norovirus strain (6). The safe and inexpensive 
therapies to control chronic norovirus infection are required. 
With the absence of small animal infection model for researching 
human norovirus (HuNoV), surrogate models such as murine 
noroviruses (MNoV) have been widely used (7). Controversies and 
limitations are always inherent how closely the effects on MNoV mimic 
HuNoVs. Any conclusions observed in MNoV model should be proven 
in HuNoV model. MNoV CR6 strain is reported to propagate in mouse 
persistently (8). Thus, this model is appropriate to evaluate effects of 
curcumin on chronic norovirus infection and analyze its mechanism. 
For many years, a variety of phytonutrients have been used in 
therapeutic remedies to enhance immune responses or resistance to 
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infectious diseases. In this study, curcumin was used. Turmeric has been 
used an important ingredient of traditional medicines (9, 10). Curcumin, 
which is constituents of turmeric has been proven to show biological and 
pharmacological effects on a variety of human health problems (11). 
Curcumin was also shown to have antimicrobial and antiviral effects (12-
14).  
Researchers have screened phytonutrients on anti-noroviral effects. 
Flavonoids are found in most plant extracts that showed anti-noviral 
effects (15-17). Other phytonutrients, such as citric acid (18), chitosan 
(19), ginsenosides (20), and proanthocyanidins (21) were reported to 
anti-noroviral effects in in vitro cell-based tests. No study evaluating 
anti-noroviral effects of phytonutrients as a therapeutic agent in mouse 
model has been reported. It is more complex than treating to target cells 
directly at higher concentration in in vitro test.  
In mouse models, the innate immune response plays a major role in 
limiting virus replication through interferon (IFN) pathway. MNoV gets 
accession to tissues through microfold (M) cells (22) which is a 
specialized cell in peyer’s patch functioning antigen sampling from 
lumen and infects dendritic cells or macrophages (23). Type I and type 
II IFNs induced by antigen-presenting cells (APC) have been shown to 
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limit virus translation (24). According to recent studies, IFN-λ (type III 
interferon) induced by MNV.CW3 strain helped with virus clearance (25). 
In another study, depletion of microbiota by antibiotics made virus fail 
to propagate intestines and enhanced type III IFNs (26) suggesting that 
gut microbiota may related to innate immunity. Similarly, enteric 
bacteria have been reported to serve as an important factor for norovirus 
infection (26, 27).  
In this study, we explored an anti-noroviral effect of curcumin using 
an animal infection model. We showed that curcumin enhanced innate 
immune responses in mice. Subsequently, microbial community change 
in tissues by curcumin was observed and a correlation between virus 












II. Materials and Methods 
1. Viruses and reagents 
Murine norovirus (MNoV) CR6 was kindly provided by Prof. Herbert 
Virgin (Washington University, St Louis, USA) and propagated in 
RAW264.7 cells maintained in Dulbecco’s Minimal Essential Medium 
(DMEM) containing 10 % fetal bovine serum (Cyclone), 10 mM sodium 
bicarbonate (Gibco), 10 mM nonessential amino acids (Gibco), 10 mM 
HEPES (Gibco), and 50 µg/ml of gentamicin (Gibco). Infected cells 
were subjected to three times of freezing-thawing cycles. Then cultures 
were purified using chloroform and concentrated by centrifugation. 
Virus stocks were aliquoted and stored at -80 °C deep freezer. Curcumin 











2. Mice and infections 
C57BL/6 (8 weeks old) female mice were purchased from Orient Bio Inc. 
(Seongnam, Korea) and housed at Seoul National University Hospital 
Biomedical Research Institute under an animal biosafety level 2 (ABL-
2) specific-pathogen-free (SPF) conditions according to University 
guidelines. Animal protocols were approved by the Seoul National 
University Institutional Animal Care and Use Committees (IACUC). 
From a week prior to virus infection, mice were inoculated with a 
curcumin (500mg/kg/day) in 0.5% carboxymethyl cellulose (CMC, 
Sigma) everyday by oral route. To control group, vehicle was treated by 
orally. Infection was performed by orally with 200 µl of DMEM 
containing viruses (106 PFU). After infection, curcumin was inoculated 
for 27 days. Stools were collected at designated time points. Tissues were 
harvested and stored in RNAlater (Ambion, TX, USA) solution and 
frozen in a liquid nitrogen directly. Stools and tissues were stored at -







3. Quantitative reverse transcription-PCR 
Quantification of viral loads in stools and tissues was performed using 
Real-time PCR using ABI 7300 (Applied Biosystems) machine. 
Comparison of antiviral gene expression was performed using Rotor-
Gene Q machine (Qiagen). Primers and probe which was used in this 
study listed in Table.1. 
3.1 Virus quantification in stools 
Stool samples were homogenized using a Vortex Adaptor (MOBIO 
Laboratories, Solana Beach, CA) with a PowerBead Tube (MOBIO) for 
10min. Total RNA was extracted using the Quick-RNA Miniprep (Zymo 
Research, Irvine, CA) kit. MNoV from stool was measured using the 
AgPath One-step RT-PCR (Ambion, Life Technologies, Carlsbad, USA) 
kit (The reaction mixture was composed of 12.5 μl of 2☓ RT-PCR Buffer, 
1 μl of 25☓ RT-PCR Enzyme Mix, 2.5 μl of template RNA, and 200nM 
primers and 100 nM probe). The cycling parameters were reverse 
transcription at 42°C for 30 min, initial denaturation at 95 °C for 10 min, 
45 cycles of denaturation at 95 °C for 15s, annealing, and extension at 
60 °C for 1 min. 
3.2 Virus quantification in tissues 
Tissue samples were homogenized PT-2000 E homogenizer 
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(POLYTRON). Total RNA from tissues was isolated with the Easy-spin 
Total RNA extraction kit (iNtRON, Korea) according to the 
manufacturer’s protocol. 1 µg of tissue RNA was used for cDNA 
synthesis with the ImPromII reverse transcriptase system (Promega, 
Madison, WI). MNoV from tissues was measured using the TaqMan 
gene expression assays (Life Technologies, NY, USA) ribosomal protein 
S29 (RPS29) of house keeping gene was used for normalization. SYBR 
green quantitative PCR for RPS29 was performed using Power SYBR 
Green PCR Master Mix (Life technologies, CA, USA). For absolute 
quantification, serial dilutions of a plasmid including MNoV or RPS29 
target sequence were used as a standard curve. Cycling parameters were 
identical to parameters used in MNoV quantification in stool assay with 
the exception of reverse transcription step.  
3.3 Relative gene expression 
For estimating expression levels of cytokine mRNA, Rotor-Gene SYBR 
Green PCR Kit (Qiagen) were used. GAPDH was used as an internal 
control. Cycling conditions were hold at 95°C for 5min and 40 cycles of 



























F represents sequences of a forward primer 
R represents sequences of a reverse primer  













4. DNA extraction and 16S rRNA sequencing 
The gut microbiome was analyzed from mouse tissue samples (cecum, 
ileum, and colon). Cecum samples containing contents were 
homogenized using a Vortex Adaptor ((MOBIO Laboratories, Solana 
Beach, CA) with a PowerBead Tube (MOBIO) for 10min. Total DNA 
from cecum was extracted using the QIAamp FAST DNA Stool kit 
(Qiagen). Colon and ileum samples were homogenized using Mini-
Beadbeater (Biospec Porudcts, Bartlesville, Oklar) with same bead tube 
used in cecum samples. DNA was extracted using G-spin Genomic DNA 
Extraction Kit (iNtRON, Korea). 
 
16S rRNA genes from total DNA of tissues were amplified using the 
515F and 806R primers specific for the V4 region, as described 
previously(28). The PCR products were run on an agarose gel to confirm 
and purified with MO BIO UltraClean PCR Clean-up Kit (MOBIO, 
Carlsbad, CA). After that, products were quantified using the KAPA 
Library Quantification Kit (KAPA Biosystems, Woburn, MA) and ABI 
7300 (Applied Biosystems) machine. Every samples were pooled and 




5. Sequence analysis 
Sequences analyzed from Miseq were processed in QIIME platform 
(v1.8.0) (29). Sequence clustering was performed with 97% identity 
using a closed-method operational taxonomic unit (OTU) picking 
method. After alignment, taxonomy was assigned to each sample using 
the Ribosomal Database Project (RDP) classifier based on the Greengene 
database. Read counts from the OTU table were used for separating 
taxons to seven levels from kingdom to species and converted to relative 














6. Bioinformatics and statistical analysis 
LDA effect size (LEfSe) (30) analysis was performed to discover specific 
microbial biomarker and characterize statistically significant differences 
between groups. Web-based galaxy module was used for LEfSe analysis. 
In that process, the Kruskal-Wallis and Wilcoxon test were used and 
threshold of logarithmic LDA score was set to 3.0. 
Non-metric dimensional scaling (NMDS) analysis, which is used for 
comparing microbial community between samples, was performed using 
the vegan package in R (31). The dissimilarity within samples was 
calculated using Bray-Curtis distance method. 
The 2(−△△𝐶T)  method (△△CT=(CT,Target-CT,Ref)treated-(CT,Target-
CT,Ref)control) was used (where CT is the threshold cycle) for calculating 
relative gene expression. 
All data were analyzed with Prism 5 (GraphPad Software, San Diego, 
CA). Statistical significance was measured using Mann-Whitney test 
when comparing two groups, two-way ANOVA with Bonferroni post-
tests comparing time course data. In all graphs, data were presented as 
mean ± sem. Statistical significance was given as * P-value <0.05, ** P-




III. Results  
 
1. Effect of curcumin on MNoV shedding in stool. 
The effects of curcumin against murine norovirus replication were 
evaluated in vivo animal model. According to experiment schemata 
(Fig.1), curcumin (500mg/kg/day) was inoculated to mice everyday by 
oral gavage from 1 week before infection for boosting their effect. At 5 
days post infection (DPI 5), stool samples were collected and analyzed 
by real-time RT-PCR. Virus shedding (3.02 ± 0.20 log10 copies/fecal) in 
stool from curcumin treated mice was reduced significantly comparing 







Figure 1. Mouse experiment schemata.  
Mice were inoculated with curcumin and infected with MNoV orally. Curcumin (500mg/kg/day) or vehicle (0.5% CMC) was inoculated everyday from 1 








Figure 2. Comparison of MNoV shedding in stool samples of curcumin or vehicle-treated mice.  
Mice were inoculated with curcumin everyday from 1 week before infection to 27 DPI. Stool was collected at day 5 after infection and viral loads were 
determined by real-time RT-PCR. Genome copies were compared between curcumin or vehicle (0.5 % CMC) in MNoV infected mice. N = 7 to 10 mice per 
each group. The dotted line represents the limit of detection (LOD). Statistical significance was analyzed by Mann-Whitney test. *P<0.05, **P<0.01.
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2. Effect of curcumin on MNoV shedding according to time course 
To confirm an effect of curcumin on virus shedding according to time 
course, stool samples were collected at other time points separately. In 
curcumin group at DPI 13, MNoV genome copies were increased by 3.78 
± 0.19 log10 copies/fecal (Fig.3A). There was no significant difference 
comparing with control group (3.42 ± 0.10 log10 copies/fecal). MNoV 
persistently replicated in majority of mice in treated and control group 




Figure 3. Time course comparison of MNoV shedding shed into fecal pellets.  
Curcumin was inoculated to MNoV infected mice everyday for evaluating antiviral effects. Viral loads were analyzed from fecal pellets collected on 5, 13, 
and 25 DPI. For comparison, genome copies were determined by real-time RT-PCR. Dashed line represents the limit of detection (LOD). Results were analyzed 
by two-way ANOVA with Bonferroni post-tests. *P<0.05. 
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3. Effect of curcumin on MNoV replication in tissues 
To confirm an effect on MNoV replication on tissues, samples were 
harvested at DPI 27 and analyzed using real-time PCR. In curcumin 
group, virus replication was significantly reduced in large intestine 1.29 
log10 (*p =0.0206) (Fig.4). Reduction was not observed in small intestine. 
Tissue specific effect was observed in other tissues. Curcumin inhibited 
virus replication in MLN (0.43 log10, *p =0.0220) and had no effect in 






Figure 4. Comparison of MNoV genome copies in intestines of curcumin or vehicle-treated mice.  
Tissue samples are harvested in curcumin or vehicle-treated (0.5% CMC) mice at DPI 27. Viral genome copies were evaluated in tissue samples using real-
time PCR and normalized with RPS29 (housekeeping gene). Dotted line represents the limit of detection (LOD). Statistical significance was measured by 













Figure 5. Effects of curcumin on MNoV replication in MLN, peyer’s patch, and cecum.  
Viral genome copies were evaluated in tissue samples using real-time PCR and normalized with RPS29 (housekeeping gene) 
at DPI 27. (A) MLN, and peyer’s patch (B) Cecum contents were used for quantification. Dotted line represents the limit of 
detection (LOD). Statistical significance was measured by Mann-Whitney test. *P<0.05. DPI = days post infection 
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4. Comparison of antiviral gene expression in tissues of curcumin 
group 
To explain tissue-specific inhibition in curcumin group, expression of 
antiviral cytokines were compared using SYBR green real-time PCR. 
Interferon-α, -β (Type I interferon), -γ (Type II interferon) were screened 
in colon, ileum, MLN (Fig.6). IFN-β was significantly promoted in colon 
and MLN (*p =0.0148 and *p =0.0315) respectively. It had no significant 
effect in ileum. The regulation of IFN-α also had similar patterns (colon; 
p =0.0431, MLN; p =0.0947, ileum; p =0.2897). IFN-γ, known as an 
important activator of macrophages resulting in immune response 
against bacteria and virus (32) was not promoted in all tissues. Thus, 






Figure 6. Effects of curcumin on the expression of interferons in tissues of MNoV infected mice.  
Interferon (IFN-α, -β, and -γ) expression relative to GAPDH was measured in tissues (colon, MLN, ileum) of curcumin or vehicle-treated (0.5% CMC) mice. 




5. Comparison of microbial diversity changes by curcumin 
treatment 
The microbiome of different tissue sites (ileum, cecum, colon) was 
analyzed across curcumin treatment. Phylotype diversity of major eight 
families was compared in Fig. 7 and statistical significance was 
measured using Mann-Whitney test between curcumin and vehicle 
treated mouse groups. Major differences were observed in cecum. In 
curcumin group, Ruminococcaceae (**p=0.0089), unclassified 
Clostridiales (***p=0.0002) were significantly increased and 
Bacteroidaceae (***p=0.0005) was decreased comparing with control 
group. No major differences were observed in colon 
(Pseudomonadaceae; p=0.5490. Clostridiaceae; p=0.6842) and ileum. 
To visualize the relationship between groups, non-metric 
multidimensional scaling (NMDS) was performed based on species level 
OTU data (Fig. 8). Points were plotted closer to each other if they have 
more similar community and vice versa. Separation between tissues were 




Figure 7. Family level diversity comparisons by curcumin treatment in MNoV infected mice. 
Average relative abundance of family level was compared across tissues and curcumin treatment. Relative abundance of each family was averaged for each 




Figure 8. Non-metric multidimensional scaling (NMDS) plot of microbial composition in MNoV infected mice. 
The NMDS was generated based on relative operational taxonomic unit (OTU) data of species level. The dissimilarity between samples were measured 




6. Characterization of specific bacteria change in colon 
To find specific microbial change in colon, we applied LDA effect size 
(LEfSe) method (30) on family level (Fig. 9A). Mogibacteriaceae was 
increased in colon (Fig. 9B). We performed same method to cecum and 
ileum samples (data not shown). The relative abundance of 








Figure 9. Significant bacterial abundances in colon according to curcumin inoculation in MNoV infected mice.  
(A) Characterization of significant abundance changes by curcumin was identified by LEfSe. Statistical analysis was measured using the 
Kruskal-Wallis test (among classes) and Wilcoxon test (between subclasses) as a p value < 0.05 in both tests. The threshold logarithmic LDA 





Figure 10. Effects of curcumin to Mogibacteriaceae abundance in MNoV 
infected mouse tissues.  
Box plots were made using species level relative operational taxonomic unit (OTU) 
data across tissues and curcumin treatment. Whiskers are plotted by Tukey method. 






7. Correlation of Mogibacteriaceae with MNoV 
Curcumin inhibited MNoV and increased Mogibacteriaceae in only 
colon. To find out correlation between MNoV virus quantity and 
abundance Mogibacteriaceae, Spearman correlation were performed. 
The correlation was significant in Spearman method with p=0.0486 and 
rho=-0.5. Thus, the abundance of the Mogibacteriaceae family was weak 



















In this study, curcumin caused an upregulation of antiviral gene 
expression resulting in inhibition of MNoV replication in colon and 
mesenteric lymph nodes (MLN). Inhibition was not observed in ileum, 
peyer’s patch (PP), and cecum. Antiviral gene expression which was 
upregulated in colon and MLN was not observed in ileum. Additionally, 
we characterized the impact of curcumin on the intestinal microbial 
community to explain antiviral responses which was restricted to large 
intestine. We identified the abundance of Mogibacteriaceae family was 
specifically changed in colon. According to Spearman’s correlation 
analysis, the amount of viruses showed negatively weak correlation with 
Mogibacteriaceae family abundance. This study characterizes 
immunomodulatory roles of curcumin related to antiviral responses and 
changes in microbial community.  
Turmeric, derived from the rhizome of the Curcuma longa is a golden 
spice widely used in Indian culture from the ancient times (11). 
Curcumin is a polyphenolic compound which gives the yellow color to 
turmeric. It is called ‘the Indian solid gold’ for its diverse biological and 
pharmacological activities such as anti-inflammatory, antioxidant, 
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antimicrobial, antiviral, and anticancer (10-13, 33). Curcumin also has 
been reported to regulate various types of immune cell growth and 
activities (34, 35). Similarly, curcumin is highly safe even at extremely 
high doses in animal model and human studies (36, 37). Curcumin 
consumption as a dietary spice ranges up to 100mg/day (38). In clinical 
test, 12g per day of curcumin is well acceptable (39).  
MNoV CR6 replicated persistently along the gastrointestinal (GI) tract 
and significantly higher in the proximal colon (25). Mesenteric lymph 
nodes (MLN) was analyzed because MNoV grows in immune cells such 
as dendritic cells, macrophages, and B cells (27, 40) and also MLN likely 
reflects the systemic infection. Microfold (M) cell in peyer’s patch (PP) 
is known as a major entry site of pathogens including norovirus (22). In 
colon and MLN, type I IFN-β was significantly upregulated in these 
tissues. It is widely known interferons (IFN) are essential to control virus 
replication on both MNoV and HuNoV (23, 41, 42). Nice et al. reported 
that C57BL/6 mice infected by MNoV CR6 strain did not induce 
detectable level of type I IFN mRNAs in MLN, peyer’s patch, and colon 
(25). Thus, curcumin induced type I IFNs in colon and MLN through 
direct or indirect way resulting in inhibition of MNoV replication. But 
its effects were specific in those tissues and had no effect on virus 
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shedding. Nice et al. compared the requirement for IFN receptors in 
control of fecal shedding (25). Virus shedding was increased in IFN-λ 
receptor knockout mouse compared with control mouse not IFN-α 
receptor knockout mouse over 35 days after infection. It means IFN-λ 
controlled fecal shedding not type I IFNs. Curcumin might not inhibit 
virus trafficking from lumen to tissues via peyer’s patch because MNoV 
inhibition was not observed in peyer’s patch. Thus far, evidences may 
indicate that curcumin induced immunomodulatory activities related to 
antiviral effects in large intestines and its effects may be transferred to 
MLN. It is the first report to identify anti-noroviral effect of curcumin 
through upregulation of antiviral IFNs. 
Additionally, microbiome analysis was performed to explain the 
inhibition of MNoV restricted to large intestines. The gastrointestinal (GI) 
tract contains diverse and numerous microbial community with 104 - 107 
bacteria / ml of ileum and 1011 - 1012 bacteria / ml in colon (43). 
Therefore, when a virus infiltrates an intestine to infect the host cell, it 
must interact with the microbiota. The interaction can be beneficial to 
host or not. Ichinohe et al. found that commensal bacteria activated 
inflammasome (44) which is required for inactivating influenza virus 
(45). On the other hand, commensal bacteria may promote viral infection 
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direct or indirect way. In the case of murine leukemia virus (MuLV), 
pathogenicity of murine leukemia virus was decreased in germ-free 
mouse (46). It was identified that commensal bacteria proliferated a 
lymphoid cell which is target cell by MuLV, thus resulting in more virus 
replication, and higher leukemia frequency. Polio virus and reovirus 
utilized bacterial LPS resulting in enhancement on their attachment to 
host cells (47). Mouse Mammary Tumor Virus (MMTV) evades antiviral 
response by activation of TLR-4 in a dendritic (DC) cell and it induces 
IL-10, acting as an immunosuppressive cytokine (48).  
In the case of norovirus, enteric bacteria have been reported to serve 
as a co-factor for norovirus infection (27). Baldridge et al. identified that 
depletion of enteric bacteria made the MNoV fail to propagate in mouse 
intestines (26).  In recent study, retinoic acid (RA) showed anti-
noroviral effect mediated by upregulation of IFN-β (49). In gut 
microbiome analysis, abundunce of Lactobacilaceae family was 
significantly increased after RA admistration. Interestingly, 
Lactobacilaceae family modulated IFN-β regulation resulting in 
inhibition of MNoV.  
In our study, systemic major bacterial community change was not 
observed in colon. In LEfSE analysis to discover specific microbial 
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change, Mogibacteriaceae family abundance significantly increased 
comparing with control group in colon. It was not observed in other 
tissues to be analyzed. The function of family Mogibacteriaceae in the 
intestine is not much known. Mogibacteriaceae were clustered with 
other microbes that are associated with lean body mass index (BMI) (50) 
and are associated with the changes of the diet containing cellulose with 
pectin, xylan in non-obese diabetic (NOD) mouse (51). Further analysis 
of family Mogibacteriaceae is required to know the relationship with 
MNoV. 
This study provided evidences curcumin inhibited MNoV replication 
mediated by type I IFN. The effects were specific in colon and MLN. 
Also, curcumin was shown to change the gut microbiota. 
Mogibacteriaceae family was significantly changed in colon. This 
changes were not observed in other tissues (cecum, ileum). Relative 
abundance of Mogibacteriaceae has weak negative correlation with the 
amount of virus. Future studies should focus on the effect of 
Mogibacteriaceae against MNoV replication and what mechanisms are 
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노로바이러스 감염으로 인한 장염발생은 전세계적으로 비세균성 위장염의 
90%를 차지한다. 감염으로 인한 증상과 잠복기는 24-48시간으로 알려져 
있으나, 면역력이 저하된 환자에게서 노로바이러스가 만성적으로 감염을 
일으키는 것으로 보고 되어있다. 이뿐 아니라 만성적으로 감염된 환자의 
숙주 내에서 노로바이러스의 변이가 일어나 또 다른 노로바이러스 집단 감
염을 일으킬 수 있다. 현재 상용화 되어 있는 치료제가 없기 때문에, 노로
바이러스를 제어할 수 있는 안전하고 접근이 용이한 치료제의 개발이 필요
하다. 식물과 영양소의 합성어이며 식물이 가지고 있는 영양소를 의미하는 
phytonutrient 는 예로부터 면역기능과 감염병에 대한 저항력 증가 효과가 
알려져 왔고, 이로 인해 전통적인 약제에 첨가되어 사용되어져 왔다. 본 실
험에서는 강황의 유효성분인 커큐민의 노로바이러스에 대한 감염 저해능을 
동물 모델을 이용하여 평가하였다. 위의 물질을 매일 쥐에게 지속적으로 
투여하고 쥐노로바이러스 (murine norovirus CR6 strain) 를 경구를 통하여 
감염시켰다. 분변과 조직에서의 바이러스 양은 실시간 중합효소 연쇄 반응
법 (realime PCR)을 이용하여 정량하였다. 그 결과, 커큐민이 결장(colon)
과 장간막 림프절(mesenteric lymph nodes)에서 바이러스의 증식을 저해
한 것을 발견하였고, 위의 조직에서 항바이러스성 인터페론 (type I 
interferon)이 유의하게 증가하였음을 발견하였다. 그러나 바이러스의 저감
은 회장(ileum)과 페이에르판(peyer’s patch)에서는 발견되지 않았다. 이러
한 현상의 원인을 장내미생물총과의 관계로 가정하고, 16S rRNA 시퀀싱을 
이용하여 장내미생물총을 분석하여 비교하였다. 분석 결과 결장속에서 
Mogibacteriaceae 의 존재비 (abundance)가 다른 조직과 달리 유의하게 
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증가하였음을 확인하였고, 바이러스 양과의 상관관계 분석에서 약한 음의 
상관관계를 보임을 확인할 수 있었다. 본 실험을 통하여 커큐민이 결장에
서 항바이러스성 인터페론을 증가시킴을 확인하였고, 이로 인해 쥐노로바
이러스의 양이 감소하였음을 확인하였다. 또한 특정한 세균이 노로바이러
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